<scp>TLR</scp>4 increases the stemness and is highly expressed in relapsed human hepatocellular carcinoma

Shuang Zhou, Renle Du, Zhenglu Wang, Wenzhi Shen, Ruifang Gao, Shan Jiang, Yan Fang, Yuzhi Shi, Antao Chang, Lei Liu,

Cancer Medicine · 2019 · 34 citations · 33 references

DOIFull text

Open access

Concepts

Abstract

Abstract Toll‐like receptor 4 ( TLR 4) plays an essential role in cancer progress. Here, we find that the expression of TLR 4 in relapsed human hepatocellular carcinoma ( HCC ) clinical samples is higher than that in the non‐relapsed ones, which leads us to explore the role of TLR 4 in cancer stemness. We reported that TLR 4‐ AKT signaling pathway was activated by lipopolysaccharides ( LPS ) in HCC cell lines to enhance the cancer stemness capacity, which was reflected by the increased percentage of CD 133 + CD 49f + population and side population, enhanced sphere formation, and the upregulation of stemness marker gene‐ SOX 2 . Downregulation of SOX 2 attenuated the enhanced HCC stemness induced by LPS , indicating SOX 2 as a downstream mediator of LPS ‐ TLR 4 signaling. The role of LPS ‐ TLR 4 signaling in inducing HCC stemness was further confirmed by tumor xenograft experiment in vivo. Taken together, our findings provide a novel therapeutic target to prevent the recurrence of HCC .

References

33